The 44 references in paper M. Khrabrova ., V. Dobronravov A., A. Nabokow ., H. Gröne -J., M. Hallensleben ., A. Smirnov V., V. Kliem ., М. Храброва С., В. Добронравов А., А. Набоков В., Х. Грене -Й., М. Халленслебен ., А. Смирнов В., Ф. Клим . (2015) “ПРОГНОЗ ВЫЖИВАЕМОСТИ ПОЧЕЧНОГО ТРАНСПЛАНТАТА: ИММУНОЛОГИЧЕСКИЙ РИСК И ТИП ОТТОРЖЕНИЯ // PROGNOSIS OF KIDNEY ALLOGRAFT SURVIVAL: IMMUNOLOGICAL RISK AND REJECTION TYPE” / spz:neicon:nefr:y:2015:i:4:p:41-50

1
Pesavento TE. Kidney Transplantation in the Context of Renal Replacement Therapy. Clin J Am Soc Nephrol 2009; 4: 2035–2039
(check this in PDF content)
2
Tonelli M, Wiebe N, Knoll G et al. Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant 2011; 11 (10): 2093-2109
(check this in PDF content)
3
El-Zoghby ZM, Stegall MD, Lager DJ et al. Identifying specific causes of kidney allograft loss. Am J Transplant 2009; 9 (3): 527-535
(check this in PDF content)
4
Naesens M, Kuypers DR, De Vusser K et al. The histology of kidney transplant failure: a long-term follow-up study. Transplantation 2014; 98 (4): 427-435
(check this in PDF content)
5
Pallardó M, Sancho CA, Capdevila PL, Franco EA. Acute rejection and late renal transplant failure: risk factors and prognosis. Nephrol Dial Transplant 2004; 19 [Suppl 3]: 38-42
(check this in PDF content)
6
Filippone EJ, Farber JL. The specificity of acute and chronic microvascular alterations in renal allografts. Clin Transplant 2013; 27 (6): 790-798
(check this in PDF content)
7
Sellares J, Freitasa DG, Mengela M et al. Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence. Am J Transplant 2012; 12: 388–399
(check this in PDF content)
8
Fidler SJ, Irish AB, Lim W et al. Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death. Transpl Immunol 2013; 28 (4): 148-153
(check this in PDF content)
9
Dunn TB, Noreen H, Gillingham K et al. Revisiting Traditional Risk Factors for Rejection and Graft Loss After Kidney Transplantation. Am J Transplant 2011; 11: 2132–2143
(check this in PDF content)
10
Loupy A, Suberbielle-Boissel C, Hill GS et al. Outcome of Subclinical Antibody-Mediated Rejection in Kidney Transplant Recipients with Preformed Donor-Specific Antibodies. Am J Transplant 2009; 9: 2561–2570
(check this in PDF content)
11
Ledesma-Gumba MA, Danguilan RA, Casasola CC, Ona ET. Efficacy of risk stratification in tailoring immunosuppression regimens in kidney transplant patients at the national kidney and transplant institute. Transplant Proc 2008; 40 (7): 2195-2197
(check this in PDF content)
12
Diet C, Audard V, Roudot-Thoraval F et al. Immunological risk in recipients of kidney transplants from extended criteria donors. Nephrol Dial Transplant 2010; 25: 2745–2753
(check this in PDF content)
13
Noël C, Abramowicz D, Durand D et al. Daclizumab versus Antithymocyte Globulin in High-Immunological-Risk Renal Transplant Recipients. JASN 2009; 20: 1385-1392
(check this in PDF content)
14
Gelder T, Tedesco Silva H, de Fijter JW et al. Renal transplant patients at high risk of acute rejection benefit from adequate exposure to mycophenolic acid. Transplantation 2010; 89 (5): 595-599
(check this in PDF content)
15
High Risk Renal Transplant Consensus Group. Defining high risk in adult kidney transplantation. Prog Transplant 2009; 19 (3): 252-258
(check this in PDF content)
16
Nascimento E, Fabreti de Oliveira RA, Maciel MD et al. Kidney Transplantation: Evaluation and Clinical Outcome of 237 Recipients at Low, Medium, High, or Strong Immunological Risk of Rejection. Transplant P 2014; 46: 101-107
(check this in PDF content)
17
Tait BD, Süsal C, Gebel HM et al. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation 2013; 95 (1): 19-47
(check this in PDF content)
18
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. Am J Transplant 2009; 9 [Suppl 3]: 1–155
(check this in PDF content)
19
Общероссийская общественная организация трансплантологов «Российское трансплантологическое общество». Национальные клинические рекомендации «Трансплантация почки» 2013 г. http://transpl.ru/specialist/rto, http:// transpl.ru/images/cms/data/pdf/nacional_nye_klinicheskie_rekomendacii_po_transplantacii_pochki.pdf. [Obscherossiyskaya obschestvennaya organizatsiya transplantologov. «Rossiyskoe transplantologicheskoe obschestvo». Natsionalnyie klinicheskie rekomendatsii «Transplantatsiya pochki» 2013 g. http://transpl.ru/ specialist/rto, http://transpl.ru/images/cms/data/pdf/nacional_ nye_klinicheskie_rekomendacii_po_transplantacii_pochki.pdf].
(check this in PDF content)
20
Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55 (2): 713-723
(check this in PDF content)
21
Haas M, Sis B, Racusen LC et al. Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions. Am J Transplant 2014; 14: 272–283
(check this in PDF content)
22
Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130(6): 461-470
(check this in PDF content)
23
Lim WH, Chapman JR, Wong G. Peak Panel Reactive Antibody, Cancer, Graft, and Patient Outcomes in Kidney Transplant Recipients. Transplantation 2014; Dec 23 [Epub ahead of print]
(check this in PDF content)
24
Kaczmarczyk M, Kotfis K, Biernawska J et al. Effect of recipient sensitization (peak panel reactive antibodies) on 15year survival after kidney transplantation. Transplant Proc 2014; 46 (8): 2699-2702
(check this in PDF content)
25
Opelz G, Döhler B, Ruhenstroth A et al. The collaborative transplant study registry. Transplant Rev (Orlando) 2013; 27 (2): 43-45
(check this in PDF content)
26
Süsal C, Döhler B, Opelz G. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report. Hum Immunol 2009; 70 (8): 569-573
(check this in PDF content)
27
Абрамов ВЮ, Мойсюк ЯГ, Калужина НН, Богданова НБ. Дифференцированное влияние совместимости по HLA-A, HLA-B и HLA-DR на выживаемость аллотрансплантата почки. Вест трансплантологии и искусственных органов 2012; 3: 1923. [Abramov VY, Moysyuk YG, Kaluzhina NN, Bogdanova NB et al. Differentsirovannoe vliyanie sovmestimosti po HLA-A, HLA-B i HLA-DR na vyizhivaemost allotransplantata pochki. Vestnik transplantologii i iskusstvennykh organov 2012; 3: 19-23]
(check this in PDF content)
28
Süsal C, Döhler B, Opelz G. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report. Hum Immunol 2009; 70 (8): 569-573
(check this in PDF content)
29
Dinis P, Nunes P, Marconi L et al. Kidney retransplantation: removal or persistence of the previous failed allograft? Transplant Proc 2014; 46 (6): 1730-1734
(check this in PDF content)
30
CTS http://www.ctstransplant.org/public/graphics/ sample.shtml
(check this in PDF content)
31
Hung SY, Lin TM, Chang MY et al. Risk factors of sensitization to human leukocyte antigen in end-stage renal disease patients. Hum Immunol 2014; 75 (6): 531-535
(check this in PDF content)
32
Fidler S, Swaminathan R, Lim W et al. Peri-operative third party red blood cell transfusion in renal transplantation and the risk of antibody-mediated rejection and graft loss. Transpl Immunol 2013; 29 (1-4): 22-27
(check this in PDF content)
33
Lebranchu Y, Baan C, Biancone L et al. Pretransplant identification of acute rejection risk following kidney transplantation. Transpl Int 2014. 27 ( 2): 129–138
(check this in PDF content)
34
Tsapepas DS, Vasilescu R, Tanriover B et al. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation. Transplantation 2014; 97 (6): 642-647
(check this in PDF content)
35
Lefaucheur C, Suberbielle-Boissel C, Hill GS et al. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Am J Transplant 2008; 8 (2): 324-331
(check this in PDF content)
36
Mohan S, Palanisamy A, Tsapepas D et al. Donor-specific antibodies adversely affect kidney allograft outcomes. Am Soc Nephrol 2012; 23 (12): 2061-2071
(check this in PDF content)
37
Marfo K, Ajaimy M, Colovai A et al. Pretransplant immunologic risk assessment of kidney transplant recipients with donorspecific anti-human leukocyte antigen antibodies. Transplantation 2014; 98 (10): 1082-1088
(check this in PDF content)
38
Souza PS, David-Neto E, Panajotopolous N et al. Dynamics of anti-human leukocyte antigen antibodies after renal transplantation and their impact on graft outcome. Clin Transplant 2014; 28 (11): 1234-1243
(check this in PDF content)
39
Ginevri F, Nocera A, Comoli P et al. Posttransplant De Novo Donor-Specific HLA Antibodies Identify Pediatric Kidney Recipients at Risk for Late Antibody-Mediated Rejection. Am J Transplant 2012; 12 (12): 3355–3362
(check this in PDF content)
40
Malheiro J, Tafulo S, Dias L et al. Posttransplant allosensitization in low immunological risk kidney and kidney-pancreas graft recipients. Biomed Res Int 2014; 2014: 438945
(check this in PDF content)
41
Kort H, Willicombe M, Brookes P et al. Microcirculation inflammation associates with outcome in renal transplant patients with de novo donor-specific antibodies. Am J Transplant 2013; 13 (2): 485-492
(check this in PDF content)
42
Buob D, Grimbert P, Glowacki F et al. Three-year outcome of isolated glomerulitis on 3-month protocol biopsies of donor HLA antibody negativepatients. Transpl Int 2012; 25 (6): 663-670
(check this in PDF content)
43
Einecke G, Sis B, Reeve J et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9 (11): 2520-2531
(check this in PDF content)
44
Nabokow A, Dobronravov VA, Khrabrova M et al. Longterm kidney allograft survival in patients with transplant glomerulitis. Transplantation 2015; 99 (2): 331-339 Авторы заявляют об отсутствии конфликта интересов.
(check this in PDF content)